ArticleThe Journal of clinical investigation2019

Profound MEK inhibitor response in a cutaneous melanoma harboring a GOLGA4-RAF1 fusion.

Christopher R McEvoy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.